Gold, the Noble metal and the paradoxes of its toxicology

Biologicals

Volumn 26, Issue 1, 1998, Pages 49-59

  Merchant, B ^a  

^a Clin/Regs Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD;

BLOOD DYSCRASIA; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG TOXICITY; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TOXICITY; NEPHROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SKIN TOXICITY; TOXICOLOGY;

EID: 0032029374     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1997.0123     Document Type: Article

References (58)

1. 1. Brown DH, Smith WE, Fox P et al. The reactions of gold (0) with amino acids and the significance of these reactions in the biochemistry of gold. Inorg Chimica Acta 1982; 67: 27-30.
2. 2. Pearson RG. Physical and inorganic chemistry: hard and soft acids and bases. J Am Chem Soc 1963; 85: 3533.
3. 3. Girling CA, Peterson RJ. Uptake, transport and localization of gold implants. Trace Subst Envir Health 1978; 12: 105.
4. 4. Beliles RP. Gold, Au. In: Clayton GD, Clayton FE, eds, Patty's Industrial Hygiene and Toxicology. 4th Edn. New York: John Wiley & Sons, Inc. 1994. 2 part C 2021-2032.
5. 5. Lewis AJ, Walz DT. Immunopharmacology of Gold. Progress in Medicinal Chemistry 1982; 19: 1-58.
6. 6. Beckwith C, Fisher A. African gold. Natl Geog 1996; 190: 36-50.
7. 7. Antonovych TT. Gold nephopathy. Ann Clin Lab Sci 1981; 11: 386-391.
8. 8. Forestier J, L-Aurotherapie Dans Les Rheumatismes Chroniques. Bull Et Mem Soc Med d'Hop de Paris 1929; 53: 323.
9. 9. Penneys NS. Gold Therapy: Dermatologic Uses and Toxicities. J Am Acad Derm 1979; 1: 315-320.
10. 10. Levinson DA, Crocker PR, Lee G, Shepherd NA, Smith AP. Unexpected Inorganic Elements in Oral Lesions: Results of X-Ray Energy Spectroscopy on Particulate Matter in Paraffin Sections. J Pathol 1984; 144: 119-129.
11. 11. Bair RL, Harris GJ, Lyon DB et al. Noninfectious inflammatory response to gold weight eyelid implants. Opthal Plas Reconstru Surg 1995; 11: 209-214.
12. 12. Pickford MA, Scamp T, Harrison DH. Morbidity after gold weight insertion into the upper eyelid in facial palsy. Br J Plas Surg 1992; 45: 460-464.
13. 13. Jobe R. Gold lid loads. Plas Reconstr Surg 1993; 91: 563-564.
14. 14. Pertmer TM, Eisenbraun MD, McCabe D et al. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995; 15: 1427-1430.
15. 15. Zwaifler NJ. Gold and automalarial therapy In: McCarty DJ, ed. Arthritis and Applied Conditions, 9th Edn, (Lee & Febiger, Philadelphia, 1979) pp. 355-364.
16. 16. Comroe BI. The use and abuse of gold therapy in rheumatoid arthritis. JAMA 1945; 128: 848-851.
17. 17. Smith PM, Smith EM, Gottlieb NL. Gold distribution in whole blood during chrysotherapy. J Lab Clin Med 1973; 82: 930-937.
18. 197Au labeled aurothiolmalate in blood; correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Arthrit Rheum 1974; 17: 171-183.
19. 19. Freyberg RH, Block WD, Levey S. Metabolism, toxicity and manner of action of gold compounds used in the treatment of arthritis. I. Human plasma and synovial fluid concentration and urinary excretion of gold during and following treatment with gold sodium thiolmalate, gold sodium thiosulfate and colloidal gold sulfide. J Clin Invest 1941; 20: 401-412.
20. 20. Gottlieb NL, Smith PM, Smith EM. Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Arthritis Rheum 1972; 15: 16-22.
21. 21. Gottlieb NL, Smith PM, Penneys NS et al. Gold concentrations in hair, nail, & skin during chrysotherapy. Arthritis Rheum 1974; 17: 56-62.
22. 22. Gottlieb NL, Smith PM, Smith EM. Gold excretion Correllated With Clinical Course During Chrysotherapy in Rheumatoid Arthritis. Arthritis Rheum 1972; 15: 582-592.
23. 23. Penneys NS, Ackerman AB, Gottlieb NL. Gold Dermatitis, A Clinical and Histopathological Study. Arch Dermatol 1974; 109: 372-376.
24. 24. Stone RL, Clafin A, Penneys NS. Erythema nodosum following gold sodium thiomalate therapy. Arch Dermatol 1973; 107: 602-604.
25. 25. Davis P. Undesirable effects of gold. J Rheumatol (Suppl.) 1979; 6: 18-24.
26. 26. Husby G, Gran JT. Risk factors in the treatment of rheumatoid arthritis with parenteral gold. Scand J Rheumatol (Suppl.) 1983; 51: 112-115.
27. 27. Lockie LM, Smith DM. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients. Semin Arth Rheum 1985; 14: 238-246.
28. 28. McKenna KE, Dolan O, Walsh MY, Burroughs D. Contact allergy to gold sodium thiolsulfate. Contact Dermatitis 1995; 32: 143-146.
29. 29. Verwilghen J, Pope RM, Panayi GS. Side effects induced by gold drugs: A graft-versus-host-like disease. J Lab Clin Med 1994; 123: 777-780.
30. 30. Cronin E. Metals. In: Contact Dermatitis. New York: Churchill Livingstone; 1980: 328-335.
31. 31. Fregert S, Kollander M, Poulsen J. Allergic contact stomatitis from gold dentures. Contact Dermatitis 1979; 5: 63-64.
32. 32. Fowler JF. Selection of patch test materials for gold allergy. Contact Dermatitis 1987; 17: 23-25.
33. 33. Wiesenfeld D, Ferguson MM, Forsyth A. Allergy to dental gold. Oral Surg 1984; 57: 158-160.
34. 34. Laeijendecker R, Van Joost T. Oral manifestations of gold allergy. J Am Acad Derm 1994; 30: 205-209.
35. 35. Bruze M, Edman B, Bjorkner B et al. Clinical relevance of contact allergy to gold sodium thiolsulfate. J Am Acad Dermatol 1994; 31: 579-583.
36. 36. Bjorkner B, Bruze M, Moller H. High frequency of contact allergy to gold sodium thiolsulfate: an indication of gold allergy? Contact Dermatitis 1994; 30: 144-151.
37. 37. Scott FR, Dhillon AP, Lewin JF, Flavell W, Laws IM. Gold granuloma after accidental implantation. J Clin Pathol 1995; 48: 1070-1071.
38. 38. Statens livsmedelsverka forfattningssamling SLV FS 1993; 1 (In Swedish).
39. 39 Russell MA, King LE Jr, Boyd AS. Lichen Planus after consumption of a cold-containing liquor. N Engl J Med 1996; 334: 603.
40. 40. Rapson WS. Skin contact with gold and gold alloys. Contact Dermatitis 1985; 13: 56-65.
41. 41. Certificate of Analysis/Compliance for Spherical Au Powder #ZG2000. Metal Group, Degussa Corp.: South Plainfield, NJ, 1993; p. 1.
42. 42. Beverly B, Couri D. Role of Myeloperoxidase (MPO) in Aurothiomalate Metabolism. Fed Proc 1987; 46: 854.
43. 2] in the formation of gold metabolites. In: Metal Based Drugs. Shaw III F, ed. London: Freund Publishing House Ltd., 1994; 1: 351-362.
44. 44. Isab AA, Sadler PJ. Reactions of gold (III) ions with ribonuclease A and methionine derivatives in aqueous solution. Biochim Biophys Acta 1977; 492: 322-330.
45. 45. Goebel C, Kubicka-Muranyi M, Tonn T et al. Phagocytes render chemicals immunogenic: oxidation of gold (I) to the T-cell sensitizing gold (III) metabolite generated by mononuclear phagocytes. Arch Toxicol 1995; 69: 450-459.
46. 46. Takahashi K, Griem P, Goebel C et al. The anti-rheumatic drug gold, a coin with two faces: Au(I) and Au(III). Desired and undesired effects on the immune system. In: Shaw III F, ed. Metal Based Drugs. London: Freund Publishing House Ltd., 1994; 1: 483-496.
47. 47. Druet Ph. Metal-induced auto-immunity. Human Exper Toxicol 1995; 14: 120-121.
48. 48. Bigazzi PE. Auto-immunity and heavy metals. Lupus 1994; 3: 449-453.
49. 49. Aoshima T, Oguchi M. Intra cytoplasmic chrystalline inclusions in dermal infiltrating cells of graunulomotus contact dermatitis due to gold earrings. Acta Derm Venereol (Stockholm) 1988; 68: 261-264.
50. 50. Fowler JF. Allergic contact dermatitis to gold. Arch Dermatol 1988; 124: 181-182.
51. 51. Izumi AK. Allergic contact gingiviostomatitis due to gold. Arch Dermatol Res 1982; 272: 387-391.
52. 52. Wicks IP, Wong D, McCullaugh RB, Fleming A. Contact allergy to gold after systemic administration of gold for rheumatoid arthritis. Ann Rheum Dis 1988; 47: 421-422.
53. 53. Kobayashi Y, Nanko H, Nakamura J, Mizoguchi M. Lymphocytoma cutis induced by gold pierced earrings. J Am Acad Derm 1992; 27: 457-458.
54. 54. Voorneveld CR, Shear NH, Rubin LA. Anaphylactic reaction after gold injection. J Rheum 1992; 19:2: 1650-1651.
55. 55. Schuhmann D, Kubicka-Muranyi M, Mirtschewa J, Gunther J, Kind P, Gleichmann E. Adverse immune reactions to gold, I chronic treatment with an Au(I) drug sensitizes mouse T-cells not to Au(I) but to Au(III) and induces autoantibody formation. J Immunol 1990; 145: 2132-2139.
56. 56. Yang NS, Christou P. Particle bombardment technology for gene transfer. Oxford, U.K.: Oxford University Press, 1994.
57. 57. Woffenden C, Ranga U, Yang ZY et al. Expression of Protective gene prolongs survival of T cells in human immunodeficiency vivus infected patients. Proc Natl Acad Sci USA 93: 2889-2894.
58. 58. Fox BA, Woffenden C, Yang ZY et al. Human Gene Therapy 1995; 6: 997-1004.